Chronic Pain
Chronic pain is pain that persists or recurs for over three months, often continuing beyond the expected period of tissue healing. It results from complex interactions involving central sensitization, neuropathic mechanisms, and altered nociceptive processing. Unlike acute pain, which serves a protective function, chronic pain is considered a distinct condition that can significantly impact physical and emotional well-being. Examples include fibromyalgia, chronic back pain, and neuropathic disorders.
Chronic pain is pain that persists or recurs for over three months, often continuing beyond the expected period of tissue healing. It results from complex interactions involving central sensitization, neuropathic mechanisms, and altered nociceptive processing. Unlike acute pain, which serves a protective function, chronic pain is considered a distinct condition that can significantly impact physical and emotional well-being. Examples include fibromyalgia, chronic back pain, and neuropathic disorders.
HBOT reduces central sensitization and promotes neuroplasticity for chronic pain management
Hyperbaric oxygen therapy (HBOT) has demonstrated potential in managing chronic pain, particularly fibromyalgia, by reducing central sensitization and improving symptoms. Studies show HBOT can outperform pharmacological treatments such as pregabalin and duloxetine, especially in fibromyalgia patients with histories of childhood trauma, improving physical, emotional, and functional outcomes. Additionally, HBOT enhances neuroplasticity by increasing pre-frontal and temporal brain activity, correlating with symptom relief. Its mechanism includes activating nitric oxide and endogenous opioids, providing significant pain relief while avoiding the side effects of opioids, making it a promising adjunct in comprehensive pain management strategies.
HBOT outperforms traditional pharmacological treatments in fibromyalgia, particularly for patients with a history of childhood trauma.
Hyperbaric oxygen therapy (HBOT) offers significant advantages for managing fibromyalgia syndrome (FMS), particularly in patients with a history of childhood sexual abuse (CSA). Compared to standard pharmacological treatments (Pregabalin and Duloxetine), HBOT demonstrated superior improvements in physical, emotional, and functional outcomes, as measured by Fibromyalgia Impact Questionnaire (FIQ) scores, pain thresholds, and conditioned pain modulation. HBOT also increased brain activity in pre-frontal and temporal regions, correlating with symptom relief and suggesting a neuroplasticity effect. These findings underscore HBOT's potential as an effective therapeutic approach for chronic pain in FMS, with benefits extending beyond symptom reduction to neural functional restoration.
HBOT outperforms traditional pharmacological treatments in fibromyalgia, particularly for patients with a history of childhood trauma.
HBOT outperforms traditional pharmacological treatments in fibromyalgia, particularly for patients with a history of childhood trauma.
HBOT provides effective pain relief by stimulating natural painkillers and enhancing brain activity, offering a safe alternative to opioids.
HBOT has been shown to effectively reduce pain in animal models. It works by stimulating the release of natural pain-relieving chemicals in the body, including nitric oxide (NO) and endogenous opioids like dynorphin. These chemicals interact with specific receptors in the spinal cord and brain to block pain signals.
HBOT offers several advantages for chronic pain management. It taps into the body's natural pain control systems, providing both short-term and longer-lasting pain relief without the side effects of opioid drugs. HBOT may be a useful option, particularly for patients who do not respond well to or want to avoid long-term opioid medication.
HBOT provides effective pain relief by stimulating natural painkillers and enhancing brain activity, offering a safe alternative to opioids.
Have more Questions?